ANNOUNCER: This is NIGHTLY BUSINESS REPORT with Tyler Mathisen and Sue Herera.

SUE HERERA, NIGHTLY BUSINESS REPORT ANCHOR: House of games. Netflix (NASDAQ:NFLX) shares soar on a strong quarter, as people around the globe sign up to watch its original shows.

…

HERERA: So, with California getting in on the battle to stem soaring drug prices, is this the best solution, letting states fix the problem or should it come from the federal government instead?

Michel Mellow is a professor of law and professor of health, research and policy at Stanford University, and she joins us now to talk about that.

Professor, welcome. It`s nice to have you with us tonight.

MICHELLE MELLO, STANFORD UNIVERSITY: Thanks.

HERERA: I guess the question we`re posing is, we know we have a problem with soaring drug prices — is it better to be federally-mandated or state-mandated?

MELLO: Well, as in many areas of health policy, the types of initiatives
that we`re seeing out of states are not the first best solution, but
they`re the solution that appears to be politically feasible at this
particular moment in time.